← Evidence map

ArticleOncotarget2018

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule.

Felix Grabenbauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule. | OpenQuestion